Biocryst Pharmaceuticals (BCRX) Capital Expenditures Growth (1y) (2011 - 2025)
Biocryst Pharmaceuticals (BCRX) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 32.28% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3,566.67% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 113.56% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.95% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -21.54% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -59.55% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -84.04% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -76.65% |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 1.78 Bn | 151.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -256.74% |
| Sep 30, 2025 | 32.96% |
| Jun 30, 2025 | 554.89% |
| Dec 31, 2024 | 141.82% |
| Sep 30, 2024 | -54.51% |
| Jun 30, 2024 | -150.32% |
| Mar 31, 2024 | 46.88% |
| Dec 31, 2023 | -406.84% |
| Sep 30, 2023 | 464.00% |
| Jun 30, 2023 | 91.39% |
| Mar 31, 2023 | -60.59% |
| Dec 31, 2022 | -52.53% |
| Sep 30, 2022 | -52.05% |
| Jun 30, 2022 | -69.99% |
| Mar 31, 2022 | 310.10% |
| Dec 31, 2021 | 614.84% |
| Sep 30, 2021 | 112.21% |
| Jun 30, 2021 | 1,045.07% |
| Mar 31, 2021 | -14.66% |
| Dec 31, 2020 | 93.75% |